Prescribing long‐acting beta₂‐ agonist inhalers in asthma

Abstract

In this series we present a number of prescribing safety indicators developed as part of an RCGP project.1 The evidence base behind each of the indicators is given along with information to illustrate their clinical significance. We provide a ‘real‐life’ audit based on the indicator to show how practices could begin to analyse their own prescribing data. Copyright © 2011 Wiley Interface Ltd

Identification of an updated set of prescribing-safety indicators for GPs

“…An intervention study will also be conducted to determine whether these indicators, as part of a larger patient safety toolkit, can be used to improve patient safety. The indicators might equally well be used for practice learning, revalidation or audit purposes (see article series in Prescriber [31][32][33][34][35][36] for examples of how this can be accomplished).…”